Repository logo
  • English
  • 中文
Log In
Have you forgotten your password?
  1. Home
  2. College of Medicine / 醫學院
  3. School of Medicine / 醫學系
  4. 利用螢光原位雜交及微矩陣技術探討多發性骨髓瘤的致病機轉(2/2)
 
  • Details

利用螢光原位雜交及微矩陣技術探討多發性骨髓瘤的致病機轉(2/2)

Other Title
Cytogenetic and interphase fluorescence in-situ hybridization (FISH) analysis of
multiple myeloma and its clinical correlation in Taiwan – a preliminary result(2/2)
Date Issued
2003
Date
2003
Author(s)
田蕙芬
DOI
912314B002131
URI
http://ntur.lib.ntu.edu.tw//handle/246246/23584
Abstract
From June 1987 to October 2003, bone marrow (BM) cells obtained from 160 patients with previously untreated multiple myeloma (MM) were analyzed by conventional cytogenetic (CC) method and 57 of the BM samples were also analyzed by interphase DNA fluorescence in situ hybridization (FISH) using multiple probes specific for chromosome 13q14, 17p13, centromeric 3, 7, 11, and 18. We aimed at (1) studying the frequency of cytogenetic aberrations in our MM patients, (2) investigating the independent significance of CC and FISH results in clinical ground, in terms of response to conventional chemotherapy, duration of response and overall survival (OS). Among those 160 patients, 109 (68.1%) were men, 51 (31.9%) were women, the median age at diagnosis was 62 years (range, 24 to 88). Fifteen (10.0%) of them were Durie-Salmon stage I, 32 (21.3%) were stage II, 50 (33.3%) were stage IIIa and 53 (35.3%) were stage IIIb. By CC analysis, cytogenetic aberrations were detected in 40 patients (25.6%). Patients with stage IIIb had higher incidence of cytogenetic aberrations than those with stage I disease, 29.4% vs. 13.3%, respectively. Among the 39 patients, complex cytogenetic aberrations occurred in 29 patients (74.4%), and 14 patients (50%) had hyperdiploidy, 6 patients (21.4%) had hypodiploidy, 2 patients (7.2%) had triploidy. The most common numeric change was trisomy 9, followed by trisomy 15 and monosomy 13. The most common structural change was 1q duplication, followed by 14q32 abnormalities, including three with t(11;14)(q13;q32) and one with t(6;14)(p21;q32). Intriguingly, add (19)(p13) was a non-random chromosome aberration, which occurred in 3 patients who all had extramedullary plasmacytomas at diagnosis. In this study, there was no significant difference in the treatment response rate (65% vs. 62.5%, p=0.846), duration of response (median, 8±4.6 vs. 12±2 months, p=0.276) or OS (median, 11±3.2 vs. 28±6.4 months, p=0.067) between those patients with cytogenetic aberrations and those without. On univariate analysis, chromosome 1q duplication was significantly associated with short OS (median, 9±2.6 vs. 27±5 months, p=0.022), so as partial or complete loss of chromosome 13 and/or abnormalities involving chromosome 11q (12±2.5 months vs. 28±7.1, p=0.028). However, on Cox stepwise regression analysis including conventional prognostic factors and the cytogenetic aberrations, only stage (p=0.003) was a independent prognostic factor for OS. In the 57 BM samples analyzed by FISH, at least one of the non-random chromosome aberrations were detected in 33 samples (57.9%), including 13q deletion in 30% of samples, 17p deletion in 5.5%, trisomy 3 in 22.2%, trisomy 7 in 24.1%, trisomy 11 in 22.2%, and trisomy 18 in 13%. Of note, FISH had higher sensitivity than CC in detecting chromosome aberrations in MM; for example, 13q & 17p deletions were found only in 11.3% and 1.9% of the patients respectively, by CC. Although 13q deletion was associated with poor response to conventional chemotherapy (46.7% vs. 72.4%, p=0.092) and short median OS (24±13 vs. 28±10.5 months, p=0.16), these differences were below the level of statistical significance, which was probably resulted from limited number of samples. In this study, trisomy 18 was associated with short duration of response (3 months vs. 14±4 months, p=0.03). In summary, 25% of our MM patients have cytogenetic aberrations by CC method. FISH revealed higher sensitivity than CC in detecting the non-random aberrations. Chromosome 1q, partial or complete loss of chromosome 13q and/or chromosome 11q abnormalities might be associated with poor clinical outcome in MM, but need to be confirmed by further studies on more patients.
Publisher
臺北市:國立臺灣大學醫學院內科
Type
report
File(s)
Loading...
Thumbnail Image
Name

912314B002131.pdf

Size

101.18 KB

Format

Adobe PDF

Checksum

(MD5):64efc6b57d9850ef449341c0a56780fe

臺大位居世界頂尖大學之列,為永久珍藏及向國際展現本校豐碩的研究成果及學術能量,圖書館整合機構典藏(NTUR)與學術庫(AH)不同功能平台,成為臺大學術典藏NTU scholars。期能整合研究能量、促進交流合作、保存學術產出、推廣研究成果。

To permanently archive and promote researcher profiles and scholarly works, Library integrates the services of “NTU Repository” with “Academic Hub” to form NTU Scholars.

總館學科館員 (Main Library)
醫學圖書館學科館員 (Medical Library)
社會科學院辜振甫紀念圖書館學科館員 (Social Sciences Library)

開放取用是從使用者角度提升資訊取用性的社會運動,應用在學術研究上是透過將研究著作公開供使用者自由取閱,以促進學術傳播及因應期刊訂購費用逐年攀升。同時可加速研究發展、提升研究影響力,NTU Scholars即為本校的開放取用典藏(OA Archive)平台。(點選深入了解OA)

  • 請確認所上傳的全文是原創的內容,若該文件包含部分內容的版權非匯入者所有,或由第三方贊助與合作完成,請確認該版權所有者及第三方同意提供此授權。
    Please represent that the submission is your original work, and that you have the right to grant the rights to upload.
  • 若欲上傳已出版的全文電子檔,可使用Open policy finder網站查詢,以確認出版單位之版權政策。
    Please use Open policy finder to find a summary of permissions that are normally given as part of each publisher's copyright transfer agreement.
  • 網站簡介 (Quickstart Guide)
  • 使用手冊 (Instruction Manual)
  • 線上預約服務 (Booking Service)
  • 方案一:臺灣大學計算機中心帳號登入
    (With C&INC Email Account)
  • 方案二:ORCID帳號登入 (With ORCID)
  • 方案一:定期更新ORCID者,以ID匯入 (Search for identifier (ORCID))
  • 方案二:自行建檔 (Default mode Submission)
  • 方案三:學科館員協助匯入 (Email worklist to subject librarians)

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science